4/A

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: February 12, 2020
Period of Report: January 27, 2020
Accession Number: 0001735276-20-000013

View Document ↗ View on SEC.gov ↗